Notícias da Leica Biosystems

Leica Biosystems is pleased to announce its latest update for In Vitro Diagnostics Regulation (IVDR) certification from the notified body BSI for the immunohistochemistry (IHC) portfolio. The IVDR is a piece of European Union legislation that aims to ensure the safety and performance of in-vitro…

Powered by Universal Access, BOND-PRIME Enables Labs to Seamlessly Adapt to Any Incoming Workflows NUSSLOCH, Germany (April 19) – Leica Biosystems announce the European launch of BOND-PRIME, a faster, more advanced staining solution. BOND-PRIME delivers all elements of Universal Access – able to…

The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug Administration (FDA) 510(k) clearance of the BOND MMR Antibody Panel, providing customers…

Leica Biosystems to adopt Paige's image management and AI system for sale with Leica Biosystems Aperio digital pathology slide scanners NEW YORK and VISTA, Calif. – March 13, 2023 – Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and Leica Biosystems,…

The history of Leica Biosystems is a history of science and technology innovation. For 150+ years, we’ve tackled pathology challenges head on – from company founder Rudolf Jung building the first microtome to today’s world-leading Digital Pathology empowering AI development. No other global company…

VISTA, Calif. (18, 2022) – Pathologists from more than 23 countries are engaged on more than 35 discussion threads on Digital Pathology Connections (DPC), a global community for professionals interested in the digital future of the anatomic pathology laboratory. Pathology professionals everywhere…